Natixis Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Natixis Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$919K	Sell	60,956 -128	-0.2%	-$2.23K	﹤0.01%	1522
2026 Q1	$1.17M	Buy	61,084 +4,063	+7%	+$88.3K	﹤0.01%	1301
2025 Q4	$1.25M	Buy	57,021 +617	+1%	+$11.1K	﹤0.01%	1192
2025 Q3	$685K	Buy	56,404 +13,992	+33%	+$189K	﹤0.01%	1422
2025 Q2	$791K	Sell	42,412 -23,161	-35%	-$459K	﹤0.01%	1364
2025 Q1	$1.26M	Sell	65,573 -105	-0.2%	-$3.07K	﹤0.01%	1215
2024 Q4	$2.37M	Buy	65,678 +1,972	+3%	+$66.7K	﹤0.01%	1044
2024 Q3	$2.7M	Buy	63,706 +10,462	+20%	+$444K	0.01%	991
2024 Q2	$2.15M	Buy	53,244 +3,034	+6%	+$127K	﹤0.01%	1026
2024 Q1	$1.78M	Buy	50,210 +15,529	+45%	+$416K	﹤0.01%	1068
2023 Q4	$1.02M	Buy	+34,681	New	+$719K	﹤0.01%	1199

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Natixis Advisors's TNDM Position: Q2 2026 in Review

Natixis Advisors reduced its Tandem Diabetes Care (TNDM) stake by 0.21% in Q2 2026, selling an estimated $2.23K and leaving 60,956 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Natixis Advisors first reported a position in TNDM in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.7M in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Natixis Advisors held 60,956 shares of Tandem Diabetes Care worth $919K as of Q2 2026.
Natixis Advisors sold 128 Tandem Diabetes Care shares in Q2 2026, an estimated $2.23K.
Tandem Diabetes Care made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1522 holding.
Natixis Advisors first reported a position in Tandem Diabetes Care in Q4 2023 and has held it in 11 quarters since.
Natixis Advisors's Tandem Diabetes Care position peaked at $2.7M in Q3 2024.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.